Vadim Fedotov has charted a diverse path from his early days as a professional basketball player with the German National Team and in the USA, to his foray into the corporate sphere, where he held significant positions as the CEO of various multinational and public companies (GRPN).

With a solid background in leadership roles, Vadim embarked on a new venture in 2018 with the launch of Bioniq in London, UK. Bioniq has established its niche in the health tech industry, offering personalized supplements based on a comprehensive analysis of blood test data. Through its expansive operations in 12 countries, the company has cultivated one of the most diverse biochemical databases globally, creating tailor-made supplement formulas that are responsive to individual nutrient deficiencies identified through blood results.

Vadim’s stewardship has guided Bioniq to become a trusted partner of eminent medical institutions like Lanserhof and King’s College Hospital, and athletic organizations including German National Teams and the UFC, catering to a broad spectrum of clients including many well-known athletes. This strategic vision has also secured backing from leading European investment funds among HV Capital (DE), Unbound (UK), Rocket Internet (DE) and Porsche Ventures (DE).

In his ongoing effort to enhance the personalized health sector, Vadim further extended the Bioniq ecosystem through the acquisition of VAHA.com, Europe’s top personalized workout platform and interactive mirror, and Loewi, Germany’s leading personalized supplement provider. These acquisitions signal Vadim’s pragmatic approach to building a synergistic and responsive ecosystem that addresses various facets of personalized health.